Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
160.3 EUR | +1.42% | +0.24% | +14.72% |
06-28 | Genmab, AbbVie's Lymphoma Therapy Recommended for Approval in EU | MT |
06-28 | AbbVie, Genmab Receive Positive European Opinion on Marketing Authorization for Possible Lymphoma Treatment | MT |